OrganoTherapeutics
Description: OrganoTherapeutics develops Parkinson's disease drugs using human-specific mini-brains for screening and testing novel drug candidates.
Country: Luxembourg
Based in: Esch-sur-alzette
Founded: 2019
Funding Stage: Seed
Tags: ['Biopharma', 'Biotechnology', 'Life Science', 'Pharmaceutical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
